← The Wire
NRXPNasdaq
NRX Pharmaceuticals, Inc.
Pharmaceutical Preparations · DE · CIK 1719406
NRx Pharmaceuticals develops novel therapeutics for central nervous system disorders, focusing on neuroplasticity
$164M
Market cap
$4.00
Last close
+7.2%
1D
+2.6%
5D
994K
Volume
Price · last 39 sessions+33.3%
May 4L $2.82 · H $4.62Jun 29
240
Total filings
Jun 4, 2026
Last filing
12/31
Fiscal year end
8-KMaterial Agreement · Company UpdateJun 4, 2026424B5FORM 424B5Jun 3, 20268-KCompany UpdateJun 2, 2026424B5FORM 424B5Jun 2, 202610-QFORM 10-QMay 15, 20268-KExecutive Change · Shareholder VoteMar 24, 202610-KFORM 10-KMar 23, 2026DEFA14AFORM DEFA14AFeb 24, 2026DEF 14AFORM DEF 14AFeb 23, 20268-KCompany UpdateFeb 17, 20268-KCompany UpdateFeb 17, 2026424B5FORM 424B5Feb 17, 20268-KExecutive ChangeFeb 2, 20268-KDelisting Notice · Reg FD DisclosureJan 16, 20268-KReg FD DisclosureDec 29, 20258-KAuditor ChangeNov 26, 20258-K/ACompany UpdateNov 21, 202510-QFORM 10-QNov 14, 20258-KReg FD Disclosure · Company UpdateOct 23, 20258-KCompany UpdateSep 26, 20258-KAcquisition / Disposition · Reg FD DisclosureSep 12, 20258-KCompany UpdateSep 8, 20258-KMaterial Agreement · Results of OperationsAug 18, 2025424B5FORM 424B5Aug 18, 202510-QFORM 10-QAug 18, 20258-KCompany UpdateAug 15, 20258-KCompany UpdateJun 9, 20258-KResults of Operations · Reg FD DisclosureMay 21, 202510-QFORM 10-QMay 15, 20258-KCompany UpdateMay 13, 202510-K/AFORM 10-K/AApr 30, 20258-KCompany UpdateApr 17, 20258-KResults of Operations · Reg FD DisclosureMar 21, 202510-KFORM 10-KMar 14, 20258-KMaterial Agreement · Company UpdateFeb 3, 20258-KMaterial Agreement · New Debt / ObligationJan 29, 20258-KExecutive Change · Company UpdateJan 22, 20258-KExecutive Change · Company UpdateJan 14, 20258-KMaterial Agreement · Equity IssuanceJan 10, 20258-KExecutive Change · Material AgreementNov 20, 20248-KResults of Operations · Reg FD DisclosureNov 15, 202410-QFORM 10-QNov 14, 2024S-1FORM S-1Nov 14, 20248-KCompany UpdateOct 31, 20248-KMaterial Agreement · New Debt / ObligationOct 15, 20248-KExecutive Change · Shareholder VoteOct 11, 2024DEF 14AFORM DEF 14ASep 5, 20248-KExecutive Change · Company UpdateAug 20, 20248-KResults of OperationsAug 15, 20248-KMaterial Agreement · New Debt / ObligationAug 14, 202410-QFORM 10-QAug 14, 20248-KDelisting Notice · Company UpdateAug 12, 20248-KAgreement Terminated · Company UpdateJun 27, 20248-KExecutive ChangeJun 20, 20248-KCompany UpdateMay 23, 20248-KResults of Operations · Reg FD DisclosureMay 16, 202410-Q10-QMay 14, 20248-KDebt Acceleration · Company UpdateApr 30, 202410-K/AFORM 10-K/AApr 29, 20248-KMaterial Agreement · Equity IssuanceApr 19, 2024424B5424B5Apr 19, 2024424B5424B5Apr 18, 20248-KCompany UpdateApr 15, 20248-KResults of OperationsApr 2, 202410-K10-KMar 29, 20248-KSecurity-Holder Rights · Bylaw AmendmentMar 28, 20248-KShareholder Vote · Reg FD DisclosureMar 21, 2024DEFA14ADEFA14AMar 20, 2024DEFA14ADEFA14AMar 18, 2024DEFA14ADEFA14AMar 13, 2024DEF 14ADEF 14AMar 11, 20248-KCompany UpdateMar 6, 20248-KMaterial Agreement · Equity IssuanceFeb 28, 2024424B5424B5Feb 28, 2024424B5424B5Feb 26, 20248-KMaterial AgreementFeb 14, 20248-KMaterial Agreement · Company UpdateFeb 14, 20248-KDelisting NoticeFeb 2, 20248-KDelisting Notice · Reg FD DisclosureJan 23, 20248-KExecutive Change · Shareholder VoteDec 29, 2023
Similar companies
Comparable business profile · signals at a glance